文献速递神经肿瘤功能神经外科

原发性与辅助性立体定向放射外科治疗海绵窦脑膜瘤:倾向性评分匹配比较分析

Primary Versus Adjuvant Stereotactic Radiosurgery for Cavernous Sinus Meningiomas: A Propensity Score-Matched Comparative Analysis.
PubMed 文献 · Neurosurgery · 2026-04-30

本研究比较症状性海绵窦脑膜瘤患者接受原发性立体定向放射外科(SRS)与初始手术联合辅助SRS的长期肿瘤控制和神经功能结局。292例患者中167例原发SRS、125例辅助SRS,倾向性评分匹配后150例。原发SRS组5年和10年肿瘤控制率更高(96.5% vs 90.5%;89.5% vs 77.8%),神经功能改善率更高(10年:39.3% vs 25.2%),神经功能恶化风险无差异。

要点

  • 原发SRS组5年肿瘤控制率96.5% vs 辅助SRS组90.5%,10年89.5% vs 77.8%。

核心结论

  • 对于症状性海绵窦脑膜瘤的初始管理,原发SRS优于初始手术联合辅助SRS。

研究设计与样本

  • 回顾性队列研究,纳入1987至2024年间接受伽玛刀放射外科的292例海绵窦脑膜瘤患者,中位随访77个月。
  • 初始管理为原发SRS者167例,手术切除后辅助SRS者125例;倾向性评分1:1匹配后150例。

临床怎么用

  • 对于症状性海绵窦脑膜瘤,可优先考虑原发SRS作为初始治疗,而非先行手术再辅助SRS。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The initial management of symptomatic cavernous sinus meningioma (CSM) remains a matter of debate. This study compares long-term tumor control and neurological outcomes in patients who underwent either primary stereotactic radiosurgery (SRS) or initial surgery followed by adjuvant SRS for both residual and progressive disease. METHODS: We identified 292 patients with CSM who underwent Gamma Knife radiosurgery between 1987 and 2024 (median follow-up, 77 months). The initial management included 167 patients who underwent primary SRS and 125 patients who had adjuvant SRS after surgical resection. Propensity score matching (1:1) was performed to control for potential selection bias differences, resulting in 150 matched patients. The primary outcomes included tumor control, neurological improvement, and neurological worsening. Kaplan-Meier analysis and logistic regression were performed. RESULTS: Compared with adjuvant SRS, primary SRS was associated with enhanced tumor control (log-rank P = .049) at 5 years (96.5% vs 90.5%) and 10 years (89.5% vs 77.8%). Neurological improvement rates were greater in the primary SRS group (10-year: 39.3% vs 25.2%, log-rank P = .008; odds ratio = 2.84, 95% CI: 1.33-6.07, P = .01), often related to improved abducens nerve function (log-rank P = .025) in primary SRS patients. The risk of neurological worsening was no different between primary and adjuvant SRS patients (P = .995). CONCLUSION: This study provides further evidence that primary SRS is a better option than initial surgery followed by adjuvant SRS for the initial management of patients with symptomatic CSM.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Yurtluk MD, Wei CZ, Reyes JS, et al. Primary Versus Adjuvant Stereotactic Radiosurgery for Cavernous Sinus Meningiomas: A Propensity Score-Matched Comparative Analysis. Neurosurgery. 2026. PMID: 42059602. doi:10.1227/neu.0000000000004071

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。